Moxifloxacin monotherapy is effective in hospitalized patients with community-acquired pneumonia: the MOTIV study--a randomized clinical trial.

Torres, Antoni

Moxifloxacin monotherapy is effective in hospitalized patients with community-acquired pneumonia: the MOTIV study--a randomized clinical trial. [electronic resource] - Clinical infectious diseases : an official publication of the Infectious Diseases Society of America May 2008 - 1499-509 p. digital

Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1537-6591

10.1086/587519 doi


Aged
Aged, 80 and over
Anti-Bacterial Agents--administration & dosage
Aza Compounds--administration & dosage
Bacteria--isolation & purification
Ceftriaxone--administration & dosage
Community-Acquired Infections--drug therapy
Double-Blind Method
Drug Therapy, Combination
Female
Fluoroquinolones
Humans
Levofloxacin
Male
Middle Aged
Moxifloxacin
Ofloxacin--administration & dosage
Pneumonia, Bacterial--drug therapy
Prospective Studies
Quinolines--administration & dosage
Severity of Illness Index
Treatment Outcome